Samuel Berman

20 papers receiving 771 citations

Peers

Samuel Berman
Comparison fields: 5 of 71
  • Hematology 178
  • Oncology 424
  • Cancer Research 162
  • Immunology 166
  • Genetics 135
Replace Dina Stroopinsky with:
Dina Stroopinsky United States
Pedro Blecua United States
Éric Charpentier United States
Lekha Mikkilineni United States
Paola Marighetti Italy
Matthew J. Frank United States
Cecilia Carpio Spain
Rachel Koldej Australia
Stefan Knackmuss Germany
Liqing Kang China
Samuel Berman relative to Dina Stroopinsky United States Dina Stroopinsky's profile →
Citations per field
00.5×5.4×
Dina Stroopinsky · 1×
Citations per year

Countries citing papers authored by Samuel Berman

Since Specialization
Citations

This map shows the geographic impact of Samuel Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Berman more than expected).

Fields of papers citing papers by Samuel Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Berman. The network helps show where Samuel Berman may publish in the future.

Co-authors

The 25 scholars most cited alongside Samuel Berman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samuel Berman Line = papers co-authored together Samuel Berman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018240
2 2017226
3 201783
4 201850
5 201643
6 201634
7 201928
8 201321
9 201418
10 202110
11 20236
12 20244
13 20244
14 19853
15 20163
16 20232
17 20162
18 20251
19 20171
20 20231

About Samuel Berman

Samuel Berman is a scholar working on Cancer Research, Dermatology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 21 papers that have together received 780 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Cancer Genomics and Diagnostics (3 papers), Electronic and Structural Properties of Oxides (3 papers), Physics of Superconductivity and Magnetism (2 papers), Breast Cancer Treatment Studies (2 papers), 2D Materials and Applications (2 papers), Immune Cell Function and Interaction (2 papers) and MXene and MAX Phase Materials (2 papers). The work is most often cited by research in Hematology (178 citations), Oncology (424 citations), Cancer Research (162 citations), Immunology (166 citations) and Genetics (135 citations). Samuel Berman has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Fabiana Perna, Michel Sadelain, Cameron Brennan, Mohamad Hamieh, Rajesh Soni, Jorge Mansilla‐Soto, Justin Eyquem, Ronald C. Hendrickson, Jorge S. Reis‐Filho and Britta Weigelt. Their work appears in journals such as Advanced Science, Physical review. B., Blood, Cancer Cell and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026